Ledger.Open graph →
SEC Form D · filed May 17, 2019

Anelixis Therapeutics, Inc

Offering
$6.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Maeve Mcnally · CAMBRIDGE, MAExecSteven Perrin · CAMBRIDGE, MAExec · DirectorAugie Nieto · CAMBRIDGE, MADirectorWalter Ogier · Boston, MADirectorMaeve Mcnally · CAMBRIDGE, MAExecSteven Perrin · CAMBRIDGE, MAExec · DirectorAugie Nieto · CAMBRIDGE, MADirectorWalter Ogier · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗